Toward Accurate in Silico Prediction of Antigen Binding Affinities for Antibody Engineering

dc.contributor.author Uluçay, T.
dc.contributor.author Arslan, M.
dc.contributor.author Döşeme, H.
dc.contributor.author Kalyoncu, S.
dc.contributor.author Kale, S.
dc.date.accessioned 2025-06-26T20:20:30Z
dc.date.available 2025-06-26T20:20:30Z
dc.date.issued 2025
dc.description.abstract In clinical applications and life sciences research, antibodies represent an important diagnostic and therapeutic potential thanks to their high target affinity, specificity, and broad developability. While the antigen affinity, one of the primary success assessors of an antibody, can be measured at reasonably high precision and reliability, the scalability of the measurements can be cumbersome and limited. This is troubling because the affinity must be monitored throughout all steps of the developability approaches such as affinity maturation and humanization of an antibody. In this context, in silico approaches present a lucrative opportunity at a fraction of the cost and time typically invested in a comparable wet lab undertaking. In addition to their high-throughput potential, in silico approaches can provide an invaluable side product, i.e., identifying the molecular driving forces behind affinity. Here, we investigated the performance of six different high-throughput servers in two settings common in antibody engineering applications: (i) de novo prediction of the experimental antibody-antigen binding constants, and (ii) the free energy change in binding due to single point mutations. We find that the accuracy of these tools can be significantly low in the two regimes relevant to antibody development: (i) prediction of high-affinity binding, and (ii) prediction of favorable mutations. These issues are intricately related to the training sets used in the underlying models of these tools where high-affinity complexes and favorable point mutations are typically underrepresented. We showed that biophysical characteristics of single point mutations, especially changes in bulkiness and hydrophobicity, increase the prediction error. We argue that while the prediction of mutational impact can be predicted within one kcal per mol using re-parameterized versions of the present in silico tools, the de novo prediction of the affinity likely requires revisiting the underlying physical models behind these tools. © 2025 en_US
dc.description.sponsorship Yükseköğretim Kurulu; IBG High-Performance Computing Facility; European Molecular Biology Organization, EMBO, (2022 No 5056); European Molecular Biology Organization, EMBO; Türkiye Bilimsel ve Teknolojik Araştırma Kurumu, TUBITAK, (119Z161); Türkiye Bilimsel ve Teknolojik Araştırma Kurumu, TUBITAK en_US
dc.identifier.doi 10.1016/bs.apcsb.2024.11.006
dc.identifier.issn 1876-1623
dc.identifier.scopus 2-s2.0-105007074823
dc.identifier.uri https://doi.org/10.1016/bs.apcsb.2024.11.006
dc.identifier.uri https://hdl.handle.net/11147/15687
dc.language.iso en en_US
dc.publisher Academic Press Inc. en_US
dc.relation.ispartof Advances in Protein Chemistry and Structural Biology en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Affinity Prediction en_US
dc.subject Antibody en_US
dc.subject Antibody-Antigen Interaction en_US
dc.subject Specificity en_US
dc.title Toward Accurate in Silico Prediction of Antigen Binding Affinities for Antibody Engineering en_US
dc.type Book Part en_US
dspace.entity.type Publication
gdc.author.scopusid 57221618198
gdc.author.scopusid 57207621369
gdc.author.scopusid 59399580500
gdc.author.scopusid 36144354500
gdc.author.scopusid 54383465100
gdc.bip.impulseclass C5
gdc.bip.influenceclass C5
gdc.bip.popularityclass C5
gdc.coar.access metadata only access
gdc.coar.type text::book::book part
gdc.collaboration.industrial false
gdc.description.department İzmir Institute of Technology en_US
gdc.description.departmenttemp [Uluçay T.] Izmir Biomedicine and Genome Center, Dokuz Eylul University Health Campus, Balçova, Izmir, Turkey, Izmir Institute of Technology, Gülbahçe Campus, Urla, Izmir, Turkey; [Arslan M.] Izmir Biomedicine and Genome Center, Dokuz Eylul University Health Campus, Balçova, Izmir, Turkey, Center for Medical Biotechnology, VIB, Ghent, Belgium; [Döşeme H.] Izmir Biomedicine and Genome Center, Dokuz Eylul University Health Campus, Balçova, Izmir, Turkey, Izmir International Biomedicine and Genome Institute, Dokuz Eylül University Health Campus, Balçova, Izmir, Turkey; [Kalyoncu S.] Izmir Biomedicine and Genome Center, Dokuz Eylul University Health Campus, Balçova, Izmir, Turkey; [Kale S.] Izmir Biomedicine and Genome Center, Dokuz Eylul University Health Campus, Balçova, Izmir, Turkey, Izmir Katip Çelebi University, Faculty of Medicine, Department of Biophysics, Çiğli, Izmir, Turkey en_US
gdc.description.publicationcategory Kitap Bölümü - Uluslararası en_US
gdc.description.scopusquality Q2
gdc.description.wosquality N/A
gdc.identifier.openalex W4410888067
gdc.index.type Scopus
gdc.oaire.diamondjournal false
gdc.oaire.impulse 0.0
gdc.oaire.influence 2.635068E-9
gdc.oaire.isgreen false
gdc.oaire.popularity 2.1091297E-10
gdc.oaire.publicfunded false
gdc.openalex.collaboration National
gdc.openalex.fwci 0.0
gdc.openalex.normalizedpercentile 0.31
gdc.openalex.toppercent TOP 10%
gdc.opencitations.count 0
gdc.plumx.scopuscites 0
gdc.scopus.citedcount 0
relation.isAuthorOfPublication.latestForDiscovery 2b36eb9f-475f-43e8-8d09-e49e4c30fa02
relation.isOrgUnitOfPublication.latestForDiscovery 9af2b05f-28ac-4026-8abe-a4dfe192da5e

Files